Topics
New Perspectives in Ocular Oncology
Applying New Data to Improve the Standard of Care in Retinal Diseases
Supported by an unrestricted educational grant from Allergan, Inc.
View Supplement
Retina 2.0
Current Management of Vitreomacular Interface Disorders
Supported by an unrestricted educational grant from ThromboGenics
Retina Imaging and Visualization
Strategies and Outcomes With Pharmacologic Vitreolysis: Perspectives From Clinical Practice
Applying New Data to Improve the Standard of Care in Retinal Diseases: The Management of Retinal Vein Occlusions
The Path to the Retina
Wide-angle Viewing for Vitreoretinal Surgery
Sponsored by Oculus
View Insert
Uveitis Update 2013
Sponsored by Bausch + Lomb
Anti-VEGF Therapy for Diabetic Macular Edema
Supported by an unrestricted educational grant from Genentech
Current and Emerging Science in Age-Related Macular Degeneration
Injection Techniques for OZURDEX® (Dexamethasone Intravitreal Implant) 0.7 mg
Sponsored by Allergan
EVA: A State-of-the-art Surgical System for Phaco-Vitrectomy
Sponsored by DORC
Updates on The Management of AMD and RVO: An Evidence-based Approach
Supported by an unrestricted educational grant from Regeneron
Diseases of the Retinal Vasculature
Applying New Data to Improve the Standard of Care in Retinal Disease
Supported by an educational grant from Allergan Inc.
Updates in Pediatric Retina
Current Treatment Options for Vitreomacular Adhesion and Macular Hole
Supported by Alcon and ThromboGenics
Vitreoretinal Surgery Updates
Free Print Subscription
Email Newsletter
Conference Calendar
October 16, 2026
Alvotech and Advanz Pharma Submit European Application for First Proposed Eylea 8 mg Biosimilar
FDA Approves Genentech's Enspryng as First At-Home Subcutaneous Treatment for Thyroid Eye Disease
October 15, 2026
Study Finds Rising Demand for Emergency Ophthalmology Consultations Across US Academic Centers
Eclipse Life Sciences Reports Positive Phase 2 Results for EC-104 in DME
